No Benefit from Chronic Lithium Dosing in a Sibling-Matched, Gender Balanced, Investigator-Blinded Trial Using a Standard Mouse Model of Familial ALS

por Gill, Alan, Kidd, Joshua, Vieira, Fernando, Thompson, Kenneth, Perrin, Steven
Publicado 2009

Dexpramipexole Is Ineffective in Two Models of ALS Related Neurodegeneration

por Vieira, Fernando G., LaDow, Eva, Moreno, Andy, Kidd, Joshua D., Levine, Beth, Thompson, Kenneth, Gill, Alan, Finkbeiner, Steven, Perrin, Steven
Publicado 2014

CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits

por Vieira, Fernando G., Hatzipetros, Theo, Thompson, Kenneth, Moreno, Andy J., Kidd, Joshua D., Tassinari, Valerie R., Levine, Beth, Perrin, Steven, Gill, Alan
Publicado 2017

SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS

por Gill, Cindy, Phelan, James P., Hatzipetros, Theo, Kidd, Joshua D., Tassinari, Valerie R., Levine, Beth, Wang, Monica Z., Moreno, Andrew, Thompson, Kenneth, Maier, Marcel, Grimm, Jan, Gill, Alan, Vieira, Fernando G.
Publicado 2019

Guanabenz Treatment Accelerates Disease in a Mutant SOD1 Mouse Model of ALS

por Vieira, Fernando G., Ping, Qinggong, Moreno, Andy J., Kidd, Joshua D., Thompson, Kenneth, Jiang, Bingbing, Lincecum, John M., Wang, Monica Z., De Zutter, Gerard S., Tassinari, Valerie R., Levine, Beth, Hatzipetros, Theo, Gill, Alan, Perrin, Steven
Publicado 2015